T1	Participants 59 80	severe bronchiectasis
T2	Participants 423 602	Twenty-four patients (12 female; mean age 51 yr) were randomized into receiving either inhaled fluticasone (500 microgram twice daily) via the Accuhaler device (n = 12) or placebo
